TickerFactsScreenerDevelopers

Immunome Inc. (IMNM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$9.60M2020: -$12.13M2021: -$18.23M2022: -$28.69M2023: -$7.57M2024: -$110.79M2025: -$190.92M-$190.92M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$190.92M-72.3%
2024-$110.79M-1364.0%
2023-$7.57M+73.6%
2022-$28.69M-57.4%
2021-$18.23M-50.2%
2020-$12.13M-26.4%
2019-$9.60M—